SEC Form 4 · accession 0001571049-17-005703
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Dagger
Officer — SVP, Gen Counsel & Corp Secy
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 6:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 1, 2017 | M | 1,150 | $11.83 | A | 1,150 | D | |
| Class A Common Stock | Jun 1, 2017 | M | 11,050 | $11.83 | A | 12,200 | D | |
| Class A Common StockF2 | Jun 1, 2017 | S | 12,200 | $35.76 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Class A Common Stock | $11.83 | Jun 1, 2017 | M | 1,150 | D | Mar 1, 2013 | Feb 28, 2019 | Class A Common Stock | 1,150 | 0 | D |
| Option to purchase Class A Common Stock | $11.83 | Jun 1, 2017 | M | 11,050 | D | Mar 1, 2014 | Feb 28, 2019 | Class A Common Stock | 11,050 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $36.38.